Manufacturers Life Insurance Company, The Cullinan Oncology, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $100 Billion
- Q1 2025
A detailed history of Manufacturers Life Insurance Company, The transactions in Cullinan Oncology, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 18,999 shares of CGEM stock, worth $147,432. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,999
Previous 24,825
23.47%
Holding current value
$147,432
Previous $302,000
52.65%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding CGEM
# of Institutions
155Shares Held
68.6MCall Options Held
15.6KPut Options Held
17.9K-
Bio Impact Capital LLC Cambridge, MA7.65MShares$59.4 Million10.72% of portfolio
-
Bvf Inc San Francisco, CA5.75MShares$44.6 Million1.91% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.86MShares$30 Million0.74% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$27.5 Million0.0% of portfolio
-
Chi Advisors LLC New York, NY3.41MShares$26.5 Million15.23% of portfolio
About Cullinan Oncology, Inc.
- Ticker CGEM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,612,200
- Market Cap $354M
- Description
- Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...